zimmytws / Shutterstock.com
Pressure is building on IP owners to offer up access to technology that could help fight COVID-19. Rory O'Neill looks at some of the implications for the patent system.
Health systems on almost every continent are threatened with being overrun by COVID-19, and face acute shortages of essential, life-saving equipment. Governments have responded with a call to arms, taking steps to facilitate the mass production of ventilators in an effort to up the capacity of intensive care units.
Those working in IP have quickly spotted the potential for patent rights to be an obstacle to this retooling effort. Governments and civil society have recognised this too, and several different remedies have been proposed in order to ensure that IP is not an impediment to the world’s COVID-19 response.
One approach that has gained traction in recent weeks is patent pools. Pressure is now building on companies with IP that could be valuable to voluntarily license it, on an open-access basis.
Life Sciences Intellectual Property Review (LSIPR) tracks the increasing challenges for intellectual property specialists in the rapidly evolving world of life sciences. From gene patents to stem cell research, we provide the very best news and analysis.
To continue reading this article and to access 4,500+ articles, our digital magazines and special reports published for LSIPR subscribers only then you will need a subscription.
If you are already subscribed please login.
Official LSIPR subscribers include:
Allen & Overy
Arnold & Siedsma
Birch, Stewart, Kolasch & Birch LLP (BSKB)
Carpmaels & Ransford
European Patent Office
George Washington Law School
Kirkland & Ellis International LLP
Marks & Clerk
NiKang Therapeutics Inc.
Powell Gilbert LLP
Procopio, Cory, Hargreaves & Savitch LLP
The United States Patent and Trademark Office (USPTO)
World Intellectual Property Office
Patent pools, COVID-19, coronavirus, pledge, Costa Rica, Frank Tietze, WHO, WIPO, Francis Gurry, IP, patents